Built Worldwide Reputation for Excellence in Custom Synthesis and Chromatography Products
Morton Grove, Illinois November 2, 2006 -
Regis Technologies, Inc. today announced that the company is celebrating its 50th anniversary. Since its opening in 1956, Regis has earned a worldwide reputation for excellence in chromatography products and its capability to synthesize complex molecules for the pharmaceutical industry. Few companies can claim this long standing history of success and innovation while continuing to grow into the future. In the midst of this milestone anniversary, the company is also celebrating expansion with a new facility and the introduction of new services.
As an innovator, Regis initially concentrated on custom synthetic chemistry for the emerging field of psychopharmacology. Later it moved into gas and liquid chromatography, and more recently developed expertise in synthesizing drugs for all stages of drug development. Today, Regis serves startup biotechnology companies and large, multinational pharmaceutical corporations helping to expedite new drugs to market.
Regis Technologies, Inc. continues to enjoy growth by providing expanded services for drug development, including process research, analytical method development, scale-up, validation, stability studies, and commercialization. Additionally, we are expanding our chromatographic separation capability by adding Supercritical Fluid Chromatography (SFC), an environmentally friendly technology. Now, with a dedicated staff and a new Synthetic Research Laboratory wing, Regis continues to broaden its capacity to serve the pharmaceutical industry.
The privately held company is family owned and operated. Regis Chairman Louis J. Glunz III, Ph.D. reflects on values and principles that his grandfather Louis Glunz I held when he started his first enterprise in the late 1800s-innovation, customer service, quality, and a commitment to community. The values and principles became the cornerstone of Regis Technologies when it first opened its doors to business in 1956. These values and principles remain alive today.
"While celebrating a half-century as chemists to the life sciences," says Regis Chairman Louis J Glunz III, Ph.D., "we're grateful for the trust and loyalty of our customers, employees, and friends. Going forward, be assured that Regis will continue to invest and remains committed to enhancing the quality of life for all."
About Regis Technologies, Inc.
Regis Technologies, Inc. is a privately held company that provides synthesis and separations services to the pharmaceutical, biotechnology, diagnostic, and other industries. Regis partners with these organizations to provide synthesis services including methods development, scale-up, and manufacture of complex, multi-step custom synthetic products. Regis provides innovative chromatography products and services, especially those with a chiral emphasis, through the utilization of our extensive organic expertise and its collegiate collaborations.